drugset / Trial / NCT06040918
Single Center Study Of N-803 Stimulation On Expansion, Enrichment, Proliferation Of Natural Killer Cells Collected By Apheresis
NaSingle-groupOpen-labelOther
Summary
This is phase 1 single cohort study evaluating the effects of N-803 administration on mononuclear cells (MNC) collected from healthy donors undergoing a procedure called apheresis.
Timeline
- Start
- 2023-10-04
- Primary completion
- 2024-09-03
- Completion
- 2024-09-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | N-803 | Protein / enzyme biologic | 1 mg | Subcutaneous |
Indications
No indication recorded.